CNN CNN Newsroom With Alisyn Camerota and Victor Blackwell February 11, 2022 19:58:00
Authorization. it turns out that according to pfizer, the study on three doses is coming through pretty quickly and they believe that they might have data available in early april. the decision was if this data will be available, why not postpone the vaccine advisory committee meeting to have that data and review it at a later date instead of reviewing two doses right now. that's what the time line is for now. this will give the agency time to consider the additional data allowing for a transparent public discussion as part of our usual scientific and regulatory processes for covid-19 vaccines...